Filing Flows › Atara Biotherapeutics (ATRA) › Next earnings date
Atara Biotherapeutics (ATRA) earnings on Nov 12, 2026: what to expect
Atara Biotherapeutics (ATRA) is expected to report earnings on Nov 12, 2026 (estimated), in 4 days, for the quarter ending Sep 30, 2026. Analysts expect EPS of −$0.22 (−$0.33 to −$0.11, 2 estimates) on revenue of $533K, against −$0.32 and $3.5M a year ago. It beat the EPS estimate in 33% of the quarters on record; Filing Flows' model gives it a 57% chance of beating next time.
What to watch
Last quarter (Q2 2026) the lines that make up revenue grew like this; the report shows whether the trend holds:
Filing Flows' own estimate from the SEC figures — the same quarter last year times recent growth — is EPS −$0.32 on revenue of $1.8M, against the analysts' −$0.22.
The last report
Atara Biotherapeutics reported revenue of $630K for the second quarter 2026 (-96% Y/Y), net loss $4.8M. How it makes money → · Every quarter →
Atara Biotherapeutics' latest quarter
Atara Biotherapeutics, Q2 2026: revenue $630K (-96% year over year), operating margin -749.2%, net loss $4.8M, operating cash flow −$3.3M. The chart follows the revenue to costs, profit and cash.
Questions
When does ATRA report earnings?
Atara Biotherapeutics is expected to report on Nov 12, 2026 (estimated).
What are analysts expecting from Atara Biotherapeutics?
EPS of −$0.22 and revenue of $533K for the quarter.
Does Atara Biotherapeutics usually beat earnings?
It beat the consensus EPS estimate in 33% of the quarters on record.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.